Department of Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, UK.
Department of Neurology, Great Ormond Street Hospital, London, UK.
Ann Neurol. 2020 Nov;88(5):867-877. doi: 10.1002/ana.25879. Epub 2020 Sep 21.
The majority of people with suspected genetic dystonia remain undiagnosed after maximal investigation, implying that a number of causative genes have not yet been recognized. We aimed to investigate this paucity of diagnoses.
We undertook weighted burden analysis of whole-exome sequencing (WES) data from 138 individuals with unresolved generalized dystonia of suspected genetic etiology, followed by additional case-finding from international databases, first for the gene implicated by the burden analysis (VPS16), and then for other functionally related genes. Electron microscopy was performed on patient-derived cells.
Analysis revealed a significant burden for VPS16 (Fisher's exact test p value, 6.9 × 10 ). VPS16 encodes a subunit of the homotypic fusion and vacuole protein sorting (HOPS) complex, which plays a key role in autophagosome-lysosome fusion. A total of 18 individuals harboring heterozygous loss-of-function VPS16 variants, and one with a microdeletion, were identified. These individuals experienced early onset progressive dystonia with predominant cervical, bulbar, orofacial, and upper limb involvement. Some patients had a more complex phenotype with additional neuropsychiatric and/or developmental comorbidities. We also identified biallelic loss-of-function variants in VPS41, another HOPS-complex encoding gene, in an individual with infantile-onset generalized dystonia. Electron microscopy of patient-derived lymphocytes and fibroblasts from both patients with VPS16 and VPS41 showed vacuolar abnormalities suggestive of impaired lysosomal function.
Our study strongly supports a role for HOPS complex dysfunction in the pathogenesis of dystonia, although variants in different subunits display different phenotypic and inheritance characteristics. ANN NEUROL 2020;88:867-877.
在进行最大程度的检查后,大多数疑似遗传性肌张力障碍患者仍未得到诊断,这意味着还有许多致病基因尚未被识别。我们旨在对此类诊断不足的情况进行研究。
我们对 138 名遗传病因不明的全身性肌张力障碍患者的外显子组测序(WES)数据进行了加权负担分析,随后在国际数据库中进一步进行了病例查找,首先针对负担分析中涉及的基因(VPS16),然后针对其他具有功能相关性的基因。对患者来源的细胞进行电子显微镜检查。
分析显示 VPS16 存在显著负担(Fisher 精确检验 p 值为 6.9×10-8)。VPS16 编码同源融合和液泡蛋白分选(HOPS)复合物的一个亚基,该复合物在自噬体-溶酶体融合中发挥关键作用。共发现 18 名个体携带杂合性失功能 VPS16 变异体,1 名个体携带微缺失。这些个体表现为早发性进行性肌张力障碍,主要累及颈部、延髓、口面和上肢。一些患者具有更复杂的表型,伴有额外的神经精神和/或发育合并症。我们还在一名婴儿起病的全身性肌张力障碍患者中发现了另一个 HOPS 复合物编码基因 VPS41 的双等位基因失功能变异体。来自 VPS16 和 VPS41 患者的患者来源的淋巴细胞和成纤维细胞的电子显微镜检查显示有空泡异常,提示溶酶体功能受损。
我们的研究强烈支持 HOPS 复合物功能障碍在肌张力障碍发病机制中的作用,尽管不同亚基的变异体表现出不同的表型和遗传特征。神经病学年鉴 2020;88:867-877。